Lataa...
Hypoxia-activated prodrugs and redox-responsive nanocarriers
Hypoxia is one of the marked features of malignant tumors, which is associated with several adaptation changes in the microenvironment of tumor cells. Therefore, targeting tumor hypoxia is a research hotspot for cancer therapy. In this review, we summarize the developing chemotherapeutic drugs for t...
Tallennettuna:
| Julkaisussa: | Int J Nanomedicine |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202002/ https://ncbi.nlm.nih.gov/pubmed/30425475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S173431 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|